| K-number | K251364 |
| Device name | Sleepiz One+ (2.5) |
| Applicant | Sleepiz AG |
| Product code | DRT |
| Device class | Class II |
| Decision date | Jul 29, 2025 |
| Decision | Substantially Equivalent |
| Regulation | 870.2300 |
Sleepiz One+ (2.5) is a contactless radar-based medical device that measures heart rate and respiration rate in resting or sleeping adult patients and detects patient presence and body movements. It consists of a hardware unit positioned near the bed and cloud-based software for data analysis and visualization, intended for use by healthcare professionals in clinical settings or by patients/caregivers at home.
Both subject and predicate devices use radar technology to collect physiological signals transmitted via internet to backend servers. The key difference is the access interface: the predicate provides a dedicated web application while the subject device provides Application Programming Interface (API) links enabling access through third-party systems. Additionally, the predicate is battery-operated while the subject device uses plug-in power, though both require power sources to operate.
Software Verification and Validation per IEC 62304:2006/A1:2015; Electrical Safety per ANSI/AAMI ES60601-1 and ANSI/AAMI HA60601-1-11; Electromagnetic Compatibility Testing per IEC 60601-1-2:2014 + A1:2020.
The subject device has identical intended use, patient population, and monitored parameters as the predicate (K223163). The transition from web-based to API-based interface and the change from battery to plug-in power are minor modifications that do not alter fundamental operation or introduce new safety/effectiveness concerns. Comprehensive verification, validation, and performance testing confirms the subject device performs comparably to the predicate under specified conditions with no new risks or scientific questions.
View the full FDA submission: accessdata.fda.gov